Previous close | 20.50 |
Open | N/A |
Bid | 22.80 |
Ask | 25.90 |
Strike | 50.00 |
Expiry date | 2024-11-15 |
Day's range | 20.50 - 20.50 |
Contract range | N/A |
Volume | |
Open interest | 21 |
Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Cheryl Pegus to its board of directors, effective immediately.
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
Nevro's (NVRO) first-quarter earnings and revenues surpass their respective Zacks Consensus Estimate. The company incurs a loss in the operating level.